Efficacy of myocardial washout of 99mTc-MIBI/Tetrofosmin for the evaluation of inflammation in patients with cardiac sarcoidosis: comparison with 18F-fluorodeoxyglucose positron emission tomography findings

[1]  Y. Kihara,et al.  JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis　- Digest Version. , 2019, Circulation journal : official journal of the Japanese Circulation Society.

[2]  V. Dilsizian,et al.  A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology , 2017, European heart journal cardiovascular Imaging.

[3]  N. Hagiwara,et al.  Regional myocardial damage and active inflammation in patients with cardiac sarcoidosis detected by non-invasive multi-modal imaging , 2017, Annals of Nuclear Medicine.

[4]  K. Sugimura,et al.  Radiologic-Pathologic Correlation of Primary and Secondary Cardiomyopathies: MR Imaging and Histopathologic Findings in Hearts from Autopsy and Transplantation. , 2017, Radiographics : a review publication of the Radiological Society of North America, Inc.

[5]  N. Hagiwara,et al.  Diagnosis and Detection of Myocardial Injury in Active Cardiac Sarcoidosis--Significance of Myocardial Fatty Acid Metabolism and Myocardial Perfusion Mismatch. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[6]  A. Burke,et al.  Cardiac sarcoidosis: the challenge of radiologic-pathologic correlation: from the radiologic pathology archives. , 2015, Radiographics : a review publication of the Radiological Society of North America, Inc.

[7]  S. Motoyama,et al.  99mTc-MIBI Washout Rate to Evaluate the Effects of Steroid Therapy in Cardiac Sarcoidosis. , 2013, Asia Oceania journal of nuclear medicine & biology.

[8]  T. Murohara,et al.  Increased (99m)Tc-sestamibi washout reflects impaired myocardial contractile and relaxation reserve during dobutamine stress due to mitochondrial dysfunction in dilated cardiomyopathy patients. , 2013, Journal of the American College of Cardiology.

[9]  K. Nakajima,et al.  Evaluation of Cardiac Mitochondrial Function by a Nuclear Imaging Technique using Technetium-99m-MIBI Uptake Kinetics , 2013, Asia Oceania journal of nuclear medicine & biology.

[10]  M. Soussan,et al.  Functional Imaging in Extrapulmonary Sarcoidosis: FDG-PET/CT and MR Features , 2013, Clinical nuclear medicine.

[11]  K. Hirata,et al.  Myocardial washout of 99mTc-tetrofosmin and response to steroid therapy in patients with cardiac sarcoidosis , 2010, Annals of nuclear medicine.

[12]  K. Hirata,et al.  The relationship between reverse redistribution of 99mTc-tetrofosmin in sub-acute phase and left ventricular functional recovery in chronic phase in patients with acute myocardial infarction , 2009, Annals of nuclear medicine.

[13]  M. Horie,et al.  A novel clinical indicator using Tc-99m sestamibi for evaluating cardiac mitochondrial function in patients with cardiomyopathies , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[14]  E. Kasper,et al.  A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. , 2005, American heart journal.

[15]  M. Nishimura,et al.  Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. , 2005, European heart journal.

[16]  W. Dassen,et al.  Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. , 2005, Journal of the American College of Cardiology.

[17]  T. Yokoyama,et al.  Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  Y. Itai,et al.  Enhanced washout of 99mTc-tetrofosmin in hypertrophic cardiomyopathy: quantitative comparisons with regional 123I-BMIPP uptake and wall thickness determined by MRI , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[19]  H. Schicha,et al.  201Tl, 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin: relative retention and clearance kinetics in retrogradely perfused guinea pig hearts. , 2002, Nuclear medicine and biology.

[20]  Y. Takeishi,et al.  Reverse redistribution of 99mTc-sestamibi after direct percutaneous transluminal coronary angioplasty in acute myocardial infarction: relationship with wall motion and functional response to dobutamine stimulation , 2001, Nuclear medicine communications.

[21]  H. Adachi,et al.  Early and delayed Tc-99m-tetrofosmin myocardial SPECT in patients with left bundle branch block , 1998, Annals of nuclear medicine.

[22]  M. Yamaki,et al.  Prediction of functional recovery in acute myocardial infarction: Comparison between sestamibi reverse redistribution and sestamibi/BMIPP mismatch , 1998, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[23]  A. Perry,et al.  Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. , 1995, Archives of pathology & laboratory medicine.

[24]  G. Beller,et al.  Physiological basis of myocardial perfusion imaging with the technetium 99m agents. , 1991, Seminars in nuclear medicine.

[25]  D. Berman,et al.  Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability. , 1990, The American journal of cardiology.

[26]  G. Johnston,et al.  Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical studies, pulmonary function studies, and bronchoalveolar lavage. , 1981, The American review of respiratory disease.

[27]  W. Reeves,et al.  Thallium-scan myocardial defects and echocardiographic abnormalities in patients with sarcoidosis without clinical cardiac dysfunction. An analysis of 44 patients. , 1980, The American journal of medicine.

[28]  Allison R. Schulman,et al.  18F-FDG PET/CT for the Assessment of Myocardial Sarcoidosis , 2013, Current Cardiology Reports.

[29]  工藤 宏計.  Myocardial washout of [99m]Tc-tetrofosmin and response to steroid therapy in patients with cardiac sarcoidosis , 2010 .

[30]  藤原 征.  The relationship between reverse redistribution of [99m]Tc-tetrofosmin in sub-acute phase and left ventricular functional recovery in chronic phase in patients with acute myocardial infarction , 2010 .

[31]  O. Sharma.  Diagnosis of cardiac sarcoidosis: an imperfect science, a hesitant art. , 2003, Chest.